For the Culture By The Culture. ISSN: 3064-9331.
New York legalized cannabis and opened hundreds of stores, but regulators now warn the legal market may not produce enough weed to keep them stocked. With nearly 600 stores open and sales nearing $3 billion, the state is discovering that legalization alone does not guarantee a functioning market.
Cannabis legalization was sold as the end of the illicit market. Instead, stacked taxes, licensing limits, and local bans created price gaps that allowed underground sales to survive. From California’s cultivation tax to Illinois pricing and Michigan’s price compression, this installment of Cannabis Lie examines how policy design, not the plant, determines who wins and who stays in the shadows.
A McMaster led analysis of two Canadian mental health surveys is getting recycled as a weed panic story, even though the design can only show association. This piece breaks down what the data can actually support, what it cannot prove, and how headlines turn survey correlations into causal claims that fuel stigma, bad policy, and lazy coverage.
Louisiana HB 373 would create a tightly controlled adult-use cannabis pilot overseen by the Louisiana Department of Health. The bill limits participation to existing medical marijuana dispensaries, imposes permit renewal fees and a 3.5 percent wholesale assessment, and sunsets July 1, 2030, forcing lawmakers to decide whether to make legalization permanent.
Arizona lawmakers are advancing legislation that would criminalize “excessive” marijuana odor detectable across property lines. Cannabis Lie Vol. 3 examines SB 1725 and SCR 1048, the proposed misdemeanor penalties, the legal implications of State v. Sisco, and why critics argue this is a backdoor attempt to reintroduce cannabis criminalization under the banner of nuisance law.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three day explanation or retest process.
